BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioForest

  Astellas and Seagen Announce Submission of Two Supplemental Biologics License Applications to the U.S. FDA for PADCEV® (enfortumab vedotin-ejfv) in Locally Advanced or Metastatic Urothelial Cancer

  Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq:SGEN) today announced completion of submissions for two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for PADCEV®

  February 18, 2021

   · 

  16 min read
• Business

  Cardinal Health collaborates with HIMSS Analytics® as Certified Organization of new CISOM maturity model

  WaveMark™ Supply Management & Workflow Solutions to help health systems improve outcomes through clinically integrated supply chain model

  February 18, 2021

   · 

  4 min read
• Improving stroke treatment with a modified therapeutic molecule

  A research team from the Institut national de la recherche scientifique has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain.

  February 18, 2021

   · 

  3 min read
• Lone Star Bio

  United Imaging Announces Agreement with Vizient for Computed Tomography Systems.

  United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced an agreement to offer its suite of cutting-edge Computed Tomography technology to Vizient members at contracted pricing.

  February 18, 2021

   · 

  3 min read
• Business

  Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021

  -- Conference Call Scheduled for 4:30 p.m. ET -- -- Company to Provide Update on Commercial Launch of Phexxi and Pivotal Phase 3 Trial of EVO100 --

  February 18, 2021

   · 

  2 min read
• Business

  Thermo Fisher Scientific Recognized with Six CMO Leadership Awards

  Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies.

  February 18, 2021

   · 

  3 min read
• Easy-to-Use Reversed-Phase Capillary Columns and Emitters Improve High-Resolution LC-MS Analysis

  The Thermo Scientific MAbPac Reversed-Phase Capillary HPLC Columns and Emitters achieve sensitive, reproducible and robust high throughput analysis with minimal sample volume

  February 18, 2021

   · 

  3 min read
• Business

  Petros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)

  Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (NASDAQ: PTPI), a leading provider of therapeutics for men’s health, today announces that Mohit Khera , M.D., M.B.A., M.P.H. has joined the company’s steering committee to develop expanded patient access initiatives for STENDRA® (avanafil) product

  February 18, 2021

   · 

  7 min read
• Business

  Emulate Names Donald Ingber to Board of Directors

  Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology

  February 18, 2021

   · 

  3 min read
• Business

  InVita Healthcare Technologies Appoints Todd Abner as Business Development Director for Blood and Plasma

  InVita Healthcare Technologies, a leading software technology provider for complex medical environments, is pleased to announce Todd Abner as the company’s new Business Development Director for Blood and Plasma.

  February 18, 2021

   · 

  2 min read